| Dr Julia Anne Rothgery, MD | |
|
2850 N 2000 W, Farr West, UT 84404-9219 | |
| (801) 731-1222 | |
| Not Available |
| Full Name | Dr Julia Anne Rothgery |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 2850 N 2000 W, Farr West, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609020072 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 7151959-1205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
RESOLUTE Partners, a leading provider of Guest Internet access and fixed wireless communications solutions for government and commercial applications has been selected to provide Patient and Guest Wi-Fi service throughout the VA San Diego Healthcare System, La Jolla Village Drive campus.
Blood vessels play a critical role in the growth and spread of cancer. The cells lining the inner wall of blood vessels (endothelial cells) and cancer cells are in close contact to each other and mutually influence each other.
Boston Scientific Corporation announces CE Mark approval and European market launch of its INGENIO and ADVANTIO pacemakers and INVIVE cardiac resynchronization therapy pacemakers.
Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the successful production of a Rotavirus VLP vaccine candidate comprising all four structural antigens of rotavirus (VP2, VP4, VP6 and VP7) using Medicago's plant-based manufacturing platform.
Onyx Pharmaceuticals, Inc. announced today that the company has begun enrollment in the ENDEAVOR trial, a Phase 3 trial evaluating Kyprolis in combination with dexamethasone, versus bortezomib with dexamethasone in patients with relapsed multiple myeloma.
› Verified 7 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
RESOLUTE Partners, a leading provider of Guest Internet access and fixed wireless communications solutions for government and commercial applications has been selected to provide Patient and Guest Wi-Fi service throughout the VA San Diego Healthcare System, La Jolla Village Drive campus.
Blood vessels play a critical role in the growth and spread of cancer. The cells lining the inner wall of blood vessels (endothelial cells) and cancer cells are in close contact to each other and mutually influence each other.
Boston Scientific Corporation announces CE Mark approval and European market launch of its INGENIO and ADVANTIO pacemakers and INVIVE cardiac resynchronization therapy pacemakers.
Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the successful production of a Rotavirus VLP vaccine candidate comprising all four structural antigens of rotavirus (VP2, VP4, VP6 and VP7) using Medicago's plant-based manufacturing platform.
Onyx Pharmaceuticals, Inc. announced today that the company has begun enrollment in the ENDEAVOR trial, a Phase 3 trial evaluating Kyprolis in combination with dexamethasone, versus bortezomib with dexamethasone in patients with relapsed multiple myeloma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julia Anne Rothgery, MD 2850 N 2000 W, Farr West, UT 84404-9219 Ph: (801) 731-1222 | Dr Julia Anne Rothgery, MD 2850 N 2000 W, Farr West, UT 84404-9219 Ph: (801) 731-1222 |
News Archive
RESOLUTE Partners, a leading provider of Guest Internet access and fixed wireless communications solutions for government and commercial applications has been selected to provide Patient and Guest Wi-Fi service throughout the VA San Diego Healthcare System, La Jolla Village Drive campus.
Blood vessels play a critical role in the growth and spread of cancer. The cells lining the inner wall of blood vessels (endothelial cells) and cancer cells are in close contact to each other and mutually influence each other.
Boston Scientific Corporation announces CE Mark approval and European market launch of its INGENIO and ADVANTIO pacemakers and INVIVE cardiac resynchronization therapy pacemakers.
Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the successful production of a Rotavirus VLP vaccine candidate comprising all four structural antigens of rotavirus (VP2, VP4, VP6 and VP7) using Medicago's plant-based manufacturing platform.
Onyx Pharmaceuticals, Inc. announced today that the company has begun enrollment in the ENDEAVOR trial, a Phase 3 trial evaluating Kyprolis in combination with dexamethasone, versus bortezomib with dexamethasone in patients with relapsed multiple myeloma.
› Verified 7 days ago
Dr. Ann Marie Schmitt, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2850 N 2000 W Ste 101, Farr West, UT 84404 Phone: 801-377-5757 | |
Dr. Bruce D Larsen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2850 N 2000 W, Farr West, UT 84404 Phone: 801-377-5757 |